Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic Cancer

Figure 2

The distribution of risk score, patient survival time, patient status, and expression level of five lncRNAs for pancreatic cancer. (a) Training set. (b) Validation set. (c) Entire cohort.

(a)

(b)

(c)